However, it is unknown whether acute CaMKII inhibition may attenuate gain-of-function effects and associated hyperexcitability caused by SCN8A epilepsy mutations, or if CaMKII can differentially modulate channel activity between diverse SCN8A polymorphisms. The gene discussed is CAMK2G; the disease is epilepsy.